Literature DB >> 5061979

Receptors on immunocompetent cells. V. Cellular correlates of the "maturation" of the immune response.

J M Davie, W E Paul.   

Abstract

During the course of the immune response to dinitrophenylated guinea pig albumin (DNP-GPA), a striking and parallel increase in avidity for epsilon-DNP-L-lysine occurs in the receptors on antigen-binding lymphocytes, antibody secreted by individual plaque-forming cells, and serum antibody molecules. A detailed analysis of the avidity distribution of antibody produced by plaque-forming cells indicates that this "immunologic maturation" is primarily due to a preservation of the high avidity subpopulation and a striking loss in the low avidity population rather than to sequential appearance of these cells. Moreover, the demonstration of the increased avidity of receptors of antigen-binding lymphocytes, which appear to be precursors of antibody-synthesizing cells, strongly suggests that the antigen-driven selectional process operates primarily on this cell type.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5061979      PMCID: PMC2139136          DOI: 10.1084/jem.135.3.660

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315.

Authors:  H N Eisen; E S Simms; M Potter
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

2.  2,4-dinitrophenyl-hapten specific hemolytic plaque-in-gel formation by mouse myeloma (MOPC-315) cells.

Authors:  H Yamada; A Yamada; V P Hollander
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

3.  Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

Authors:  M B Rittenberg; K L Pratt
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

4.  Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation.

Authors:  V J Pasanen; O Mäkelä
Journal:  Immunology       Date:  1969-03       Impact factor: 7.397

5.  Determination of antibody-hapten equilibrium constants by an ammonium sulfate precipitation technique.

Authors:  Y Stupp; T Yoshida; W E Paul
Journal:  J Immunol       Date:  1969-09       Impact factor: 5.422

6.  Receptors on immunocompetent cells. II. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding lymphocytes of normal guinea pigs.

Authors:  J M Davie; W E Paul
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

7.  In vitro-initiated secondary anti-hapten response. II. Increasing cell avidity for antigen.

Authors:  W W Bullock; M B Rittenberg
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

8.  Studies on the regulation of avidity at the level of the single antibody-forming cell. The effect of antigen dose and time after immunization.

Authors:  B Andersson
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

9.  Carrier function in anti-hapten antibody responses. IV. Experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "nonimmunogenic" hapten-polypeptide conjugates.

Authors:  D H Katz; J M Davie; W E Paul; B Benacerraf
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

10.  Sequential changes in the relative affinity of antibodies synthesized during the immune response.

Authors:  L A Steiner; H N Eisen
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

View more
  29 in total

1.  Age-dependent changes in the relative affinity of anti-dinitrophenyl antibodies in mice.

Authors:  S Marshall-Clarke; J H Playfair
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

2.  Enrichment of memory cells carrying receptors for a protein antigen (HSA). II. Improved enrichment technique, using BSA density gradient separation.

Authors:  R Tanenbaum; D Sulitzeanu
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

3.  A mathematical model of the effect of immunogenicity on therapeutic protein pharmacokinetics.

Authors:  Xiaoying Chen; Timothy Hickling; Eugenia Kraynov; Bing Kuang; Chuenlei Parng; Paolo Vicini
Journal:  AAPS J       Date:  2013-08-30       Impact factor: 4.009

4.  Mapping of antibody specificities to VH gene families.

Authors:  G Kelsoe; R Miceli; J Cerny; D H Schulze
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  The adoptive secondary response to human serum albumin under conditions of high antigen pressure. The response of high and low avidity B cell subsets.

Authors:  E B Bell; F L Shand
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

6.  Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response.

Authors:  T P Werblin; Y T Kim; F Quagliata; G W Siskind
Journal:  Immunology       Date:  1973-03       Impact factor: 7.397

7.  Immunoglobulin receptors on human leucocytes. 3. Comparative study of human bone marrow and blood B cells: role of IgM receptors.

Authors:  N I Abdou; N L Abdou
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

8.  Specific fractionation of immune cell populations.

Authors:  U Rutishauser; C F Millette; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Comparative study of bone marrow and blood B cells in infantile and acquired agammaglobulinemia. Possible role of circulating anti-IgM in pathogenesis.

Authors:  N I Abdou; S R Casella; N L Abdou; I A Abrahamsohn
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

10.  Studies on the control of antibody synthesis. VII. Change in affinity of direct and indirect plaque-forming cells with time after immunization in the mouse: loss of high affinity plaques late after immunization.

Authors:  E A Goidl; J J Barondess; G W Siskind
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.